The Ovary

  • Debra L. Friedman
Part of the Pediatric Oncology book series (PEDIATRICO)


Clin Oncol Radiat Oncol Biol Phys Childhood Cancer Ovarian Function Ovarian Failure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Palter S, Olive D (2002) Reproductive physiology. In: Berek J, Adams Hillard P, Adashi E (eds) Novak's gynecology. Lippincott Williams and Wilkins, Philadelphia, pp 163–164Google Scholar
  2. 2.
    Chapman RM, Sutcliffe SB, Malpas JS (1979) Cytotoxic induced ovarian failure in women with Hodgkin's disease. JAMA 242:1877–1881CrossRefPubMedGoogle Scholar
  3. 3.
    Shalet SM (1996) Endocrine sequelae of cancer therapy. Eur J Endocrinol 135:135–143PubMedGoogle Scholar
  4. 4.
    Syrjala KL, Roth-Roemer SL, Abrams JR, Scanlan JM, Chapko MK, Visser S, Sanders JE (1998) Prevalence and predictors of sexual dysfunction in long-term survivors of marrow transplantation. J Clin Oncol 16:3148–3157PubMedGoogle Scholar
  5. 5.
    Constine LS (1991) Late effects of radiation therapy. Pediatrician 18:37–48PubMedGoogle Scholar
  6. 6.
    Wallace WH, Shalet SM, Hendry JH, Morris-Jones PH, Gattamaneni HR (1989) Ovarian failure following abdominal irradiation in childhood:the radiosensitivity of the human oocyte. Br J Radiol 62:995–998PubMedGoogle Scholar
  7. 7.
    Ash P (1980) The influence of radiation on fertility in man. Br J Radiol 53:271–278PubMedGoogle Scholar
  8. 8.
    Lushbaugh CC, Casarett GW (1976) The effects of gonadal irradiation in clinical radiation therapy:a review. Cancer 37[Suppl 2]:1111–1125PubMedGoogle Scholar
  9. 9.
    Byrne J, Mulvihill JJ, Myers MH, Connelly RR, Naughton MD, Krauss MR, Steinhorn SC, Hassinger DD, Austin DF, Bragg K (1987) Effects of treatment on fertility in long-term survivors of childhood or adolescent cancer. N Engl J Med 317:1315–1321PubMedGoogle Scholar
  10. 10.
    Nicosia SV, Matus-Ridley M, Meadows AT (1985) Gonadal effects of cancer therapy in girls. Cancer 55:2364–2372PubMedGoogle Scholar
  11. 11.
    Damewood MD, Grochow LB (1986) Prospects for fertility after chemotherapy or radiation for neoplastic disease. Fertil Steril 45:443–459PubMedGoogle Scholar
  12. 12.
    Bath LE, Hamish W, Wallace B, Critchley HO (2002) Late effects of the treatment of childhood cancer on the female reproductive system and the potential for fertility preservation. BJOG:an Int J Obst et Gynaecol 109:107–114CrossRefGoogle Scholar
  13. 13.
    Hill M, Milan S, Cunningham D, Mansi J, Smith I, Catovsky D, Gore M, Zulian G, Selby P, Horwich A et al. (1995) Evaluation of the efficacy of the VEEP regimen in adult Hodgkin's disease with assessment of gonadal and cardiac toxicity (see comments). Comment in:J Clin Oncol 1995, 13:1283–1284. J Clin Oncol 13:387–395Google Scholar
  14. 14.
    Mayer EI, Dopfer RE, Klingebiel T, Scheel-Walter H, Ranke MB, Niethammer D (1999) Longitudinal gonadal function after bone marrow transplantation for acute lymphoblastic leukemia during childhood. Pediatric Transplant 3:38–44CrossRefGoogle Scholar
  15. 15.
    Thomson AB, Critchley HO, Kelnar CJ, Wallace WH (2002) Late reproductive sequelae following treatment of childhood cancer and options for fertility preservation. Best Pract Res Clin Endocrinol Metab 16:311–334CrossRefPubMedGoogle Scholar
  16. 16.
    Stillman RJ, Schinfeld JS, Schiff I, Gelber RD, Greenberger J, Larson M, Jaffe N, Li FP (1981) Ovarian failure in long-term survivors of childhood malignancy. Am J Obstet Gynecol 139:62–66PubMedGoogle Scholar
  17. 17.
    Halperin EC (1993) Concerning the inferior portion of the spinal radiotherapy field for malignancies that disseminate via the cerebrospinal fluid. Int J Radiat Oncol Biol Phys 26:357–362PubMedGoogle Scholar
  18. 18.
    Critchley HO, Bath LE, Wallace WH (2002) Radiation damage to the uterus — review of the effects of treatment of childhood cancer. Hum Fertil (Camb) 5:61–66Google Scholar
  19. 19.
    Sklar C, Boulad F, Small T, Kernan N (2001) Endocrine complications of pediatric stem cell transplantation. Front Biosci 6:G17–G22PubMedGoogle Scholar
  20. 20.
    Ogilvy-Stuart AL, Clark DJ, Wallace WH, Gibson BE, Stevens RF, Shalet SM, Donaldson MD (1992) Endocrine deficit after fractionated total body irradiation. Arch Dis Child 67:1107–1110PubMedGoogle Scholar
  21. 21.
    Sklar CA (1991) Growth and pubertal development in survivors of childhood cancer. Pediatrician 18:53–60PubMedGoogle Scholar
  22. 22.
    Howell S, Shalet S (1998) Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin North Am 27:927–943CrossRefPubMedGoogle Scholar
  23. 23.
    Kreuser ED, Xiros N, Hetzel WD, Heimpel H (1987) Reproductive and endocrine gonadal capacity in patients treated with COPP chemotherapy for Hodgkin's disease. J Cancer Res Clin Oncol 113:260–266CrossRefPubMedGoogle Scholar
  24. 24.
    Chiarelli AM, Marrett LD, Darlington G (1999) Early menopause and infertility in females after treatment for childhood cancer diagnosed in 1964–1988 in Ontario, Canada. Am J Epidemiol 150:245–254PubMedGoogle Scholar
  25. 25.
    Hudson MM (2002) Pediatric Hodgkin's therapy:time for a paradigm shift. J Clin Oncol 20:3755–3757PubMedGoogle Scholar
  26. 26.
    Linch DC, Gosden RG, Tulandi T, Tan SL, Hancock SL (2000) Hodgkin's lymphoma:choice of therapy and late complications. Hematology (Am Soc Hematol Educ Program) 205–221Google Scholar
  27. 27.
    Schwartz CL (2003) The management of Hodgkin disease in the young child. Curr Opin Pediatr 15:10–16CrossRefPubMedGoogle Scholar
  28. 28.
    Santoro A, Valagussa P (1992) Advances in the treatment of Hodgkin's disease. Curr Opin Oncol 4:821–828PubMedGoogle Scholar
  29. 29.
    Hamilton VM, Norris C, Bunin N, Goldwein JW, Bunin GR, Lange B, Meadows AT (2001) Cyclophosphamide-based, seven-drug hybrid and low-dose involved field radiation for the treatment of childhood and adolescent Hodgkin disease. J Pediatr Hematol Oncol 23:84–88CrossRefPubMedGoogle Scholar
  30. 30.
    Hudson MM, Greenwald C, Thompson E, Wilimas J, Marina N, Fairclough D, Kauffman W, Bozeman P, Mackert PW, Abromowitch M et al. (1993) Efficacy and toxicity of multi-agent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease. J Clin Oncol 11:100–108PubMedGoogle Scholar
  31. 31.
    Longhi A, Pignotti E, Versari M, Asta S, Bacci G (2003) Effect of oral contraceptive on ovarian function in young females undergoing neoadjuvant chemotherapy treatment for osteosarcoma. Oncol Rep 10:151–155PubMedGoogle Scholar
  32. 32.
    Sanders JE, Buckner CD, Leonard JM, Sullivan KM, Witherspoon RP, Deeg HJ, Storb R, Thomas ED (1983) Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation. Transplantation 36: 252–255PubMedGoogle Scholar
  33. 33.
    Teinturier C, Hartmann O, Valteau-Couanet D, Benhamou E, Bougneres PF (1998) Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure. Bone Marrow Transplant 22:989–994CrossRefPubMedGoogle Scholar
  34. 34.
    Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ, Doney K, Storb R, Sullivan K, Witherspoon R, Appelbaum FR (1996) Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 87:3045–3052PubMedGoogle Scholar
  35. 35.
    Green DM, Whitton JA, Stovall M, Mertens AC, Donaldson SS, Ruymann FB, Pendergrass TW, Robison LL (2002) Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Am J Obstet Gynecol 187:1070–1080CrossRefPubMedGoogle Scholar
  36. 36.
    Green DM, Peabody EM, Nan B, Peterson S, Kalapurakal JA, Breslow NE (2002) Pregnancy outcome after treatment for Wilms’ tumor: a report from the National Wilms’ Tumor Study Group. J Clin Oncol 20:2506–2513CrossRefPubMedGoogle Scholar
  37. 37.
    Green DM, Fiorello A, Zevon MA, Hall B, Seigelstein N (1997) Birth defects and childhood cancer in offspring of survivors of childhood cancer. Arch Pediatr Adolesc Med 151:379–383PubMedGoogle Scholar
  38. 38.
    Byrne J, Rasmussen SA, Steinhorn SC, Connelly RR, Myers MH, Lynch CF, Flannery J, Austin DF, Holmes FF, Holmes GE, Strong LC, Mulvihill JJ (1998) Genetic disease in offspring of long-term survivors of childhood and adolescent cancer (comment). Am J Hum Genet 62:45–52PubMedGoogle Scholar
  39. 39.
    Sankila R, Olsen JH, Anderson H, Garwicz S, Glattre E, Hertz H, Langmark F, Lanning M, Moller T, Tulinius H (1998) Risk of cancer among offspring of childhood-cancer survivors. Association of the Nordic Cancer Registries and the Nordic Society of Paediatric Haematology and Oncology (comment). N Engl J Med 338:1339–1344CrossRefPubMedGoogle Scholar
  40. 40.
    Rosenfield RL (2002) Puberty in the female. In: Sperling MA (ed) Pediatric endocrinology. Saunders, PhiladelphiaGoogle Scholar
  41. 41.
    Hudson MM, Donaldson SS (1999) Treatment of pediatric Hodgkin's lymphoma. Semin Hematol 36:313–323PubMedGoogle Scholar
  42. 42.
    Kelly KM, Hutchinson RJ, Sposto R, Weiner MA, Lones MA, Perkins SL, Massey V (2002) Feasibility of upfront dose-intensive chemotherapy in children with advanced-stage Hodgkin's lymphoma: preliminary results from the Children's Cancer Group Study CCG-59704. Ann Oncol 13[Suppl 1]:107–111PubMedGoogle Scholar
  43. 43.
    Donaldson SS, Hudson MM, Lamborn KR, Link MP, Kun L, Billett AL, Marcus KC, Hurwitz CA, Young JA, Tarbell NJ, Weinstein HJ (2002) VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: results of a prospective clinical trial. J Clin Oncol 20:3081–3087CrossRefPubMedGoogle Scholar
  44. 44.
    Nachman JB, Sposto R, Herzog P, Gilchrist GS, Wolden SL, Thomson J, Kadin ME, Pattengale P, Davis PC, Hutchinson RJ, White K (2002) Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy. J Clin Oncol 20:3765–3771CrossRefPubMedGoogle Scholar
  45. 45.
    Ortin TT, Shostak CA, Donaldson SS (1990) Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience (see comments). Int J Radiat Oncol Biol Phys 19:873–880PubMedGoogle Scholar
  46. 46.
    Haie-Meder C, Mlika-Cabanne N, Michel G, Briot E, Gerbaulet A, Lhomme C, Cosset JM, Sarrazin D, Flamant F, Hayat M (1993) Radiotherapy after ovarian transposition: ovarian function and fertility preservation. Int J Radiat Oncol Biol Phys 25:419–424PubMedGoogle Scholar
  47. 47.
    Blumenfeld Z, Dann E, Avivi I, Epelbaum R, Rowe JM (2002) Fertility after treatment for Hodgkin's disease. Ann Oncol 13[Suppl 1]:138–147PubMedGoogle Scholar
  48. 48.
    Blumenfeld Z, Avivi I, Linn S, Epelbaum R, Ben-Shahar M, Haim N (1996) Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy. Hum Reprod 11:1620–1626PubMedGoogle Scholar
  49. 49.
    Pereyra Pacheco B, Mendez Ribas JM, Milone G, Fernandez I, Kvicala R, Mila T, di Noto A, Contreras Ortiz O, Pavlovsky S (2001) Use of GnRH analogs for functional protection of the ovary and preservation of fertility during cancer treatment in adolescents: a preliminary report. Gynecol Oncol 81:391–397CrossRefPubMedGoogle Scholar
  50. 50.
    Bahadur G, Steele S (1996) Ovarian tissue cryopreservation for patients. Hum Reprod 11:2215–2216PubMedGoogle Scholar
  51. 51.
    Donnez J, Godin P, Qu J, Nisolle M (2000) Gonadal cryopreservation in the young patient with gynaecological malignancy. Curr Opin Obstet Gynecol 12:1–9CrossRefPubMedGoogle Scholar
  52. 52.
    Newton H (1998) The cryopreservation of ovarian tissue as a strategy for preserving the fertility of cancer patients. Hum Reprod Update 4:237–247CrossRefPubMedGoogle Scholar
  53. 53.
    Ericson A, Kallen B (2001) Congenital malformations in infants born after IVF: a population-based study. Hum Reprod 16:504–509CrossRefPubMedGoogle Scholar
  54. 54.
    Bonduelle M, Liebaers I, Deketelaere V, Derde MP, Camus M, Devroey P, van Steirteghem A (2002) Neonatal data on a cohort of 2889 infants born after ICSI (1991–1999) and of 2995 infants born after IVF (1983–1999). Hum Reprod 17:671–694CrossRefPubMedGoogle Scholar
  55. 55.
    Hansen M, Kurinczuk JJ, Bower C, Webb S (2002) The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization. N Engl J Med 346:725–730CrossRefPubMedGoogle Scholar
  56. 56.
    Serafini P (2001) Outcome and follow-up of children born after IVF-surrogacy. Hum Reprod Update 7:23–27CrossRefPubMedGoogle Scholar
  57. 57.
    Simpson JL, Lamb DJ (2001) Genetic effects of intracytoplasmic sperm injection. Semin Reprod Med 19:239–249CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Debra L. Friedman

There are no affiliations available

Personalised recommendations